GTC Wins Biogen Contract, Hits Schering Milestone | GenomeWeb

WALTHAM, Mass.--Genome Therapeutics has begun work on a sequencing contract for Biogen. Genome Therapeutics will employ its proprietary sequencing techniques, automation, bioinformatics, and quality control procedures to generate desired sequence reads and provide analysis of sequenced regions for Biogen.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.